School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Phytother Res. 2021 Sep;35(9):4834-4897. doi: 10.1002/ptr.7119. Epub 2021 Jun 26.
Gastrointestinal (GI) cancers with a high global prevalence are a leading cause of morbidity and mortality. Accordingly, there is a great need to develop efficient therapeutic approaches. Curcumin, a naturally occurring agent, is a promising compound with documented safety and anticancer activities. Recent studies have demonstrated the activity of curcumin in the prevention and treatment of different cancers. According to systematic studies on curcumin use in various diseases, it can be particularly effective in GI cancers because of its high bioavailability in the gastrointestinal tract. Nevertheless, the clinical applications of curcumin are largely limited because of its low solubility and low chemical stability in water. These limitations may be addressed by the use of relevant analogues or novel delivery systems. Herein, we summarize the pharmacological effects of curcumin against GI cancers. Moreover, we highlight the application of curcumin's analogues and novel delivery systems in the treatment of GI cancers.
具有高全球流行率的胃肠道(GI)癌症是发病率和死亡率的主要原因。因此,非常需要开发有效的治疗方法。姜黄素是一种天然存在的物质,具有已证明的安全性和抗癌活性,是一种很有前途的化合物。最近的研究表明姜黄素在预防和治疗不同癌症方面具有活性。根据对姜黄素在各种疾病中的应用的系统研究,由于其在胃肠道中的高生物利用度,它对胃肠道癌症可能特别有效。然而,由于其在水中的低溶解度和低化学稳定性,姜黄素的临床应用在很大程度上受到限制。这些限制可以通过使用相关类似物或新型传递系统来解决。在此,我们总结了姜黄素对胃肠道癌症的药理作用。此外,我们还强调了姜黄素类似物和新型传递系统在治疗胃肠道癌症中的应用。